Harrol Hutchison
Neurology · Fresno, CANPI 1831155654
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Philips North America LLC at 32.5% of the total. Reporting peaked in 2019 at $1,646 and has fallen 88.0% since, to $198 in 2025.
Across 194 payments — averaging $22.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$1K
- Livanova USA, Inc.$544
- Teva Pharmaceuticals USA, Inc.$500
- Eisai Inc.$323
- Jazz Pharmaceuticals Inc.$240
- Greenwich Biosciences, Inc.$179
- plus $1K from 13 others
What the payments were for
- Food & beverage$4,37899%
- Education$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 105 | $1,442 |
| Livanova USA, Inc. | 13 | $544 |
| Teva Pharmaceuticals USA, Inc. | 18 | $500 |
| Eisai Inc. | 9 | $323 |
| Jazz Pharmaceuticals Inc. | 4 | $240 |
| Greenwich Biosciences, Inc. | 3 | $179 |
| Biogen | 6 | $170 |
| UCB, Inc. | 3 | $169 |
| Novartis | 3 | $153 |
| Medtronic(2 entities) | 4 | $142 |
| Electromed, Inc. | 6 | $136 |
| Catalyst Pharmaceuticals, Inc. | 3 | $69 |
| AbbVie(2 entities) | 3 | $63 |
| Zogenix Inc. | 3 | $61 |
| Sunovion Pharmaceuticals Inc. | 3 | $55 |
| Advanced Respiratory, Inc | 2 | $54 |
| AstraZeneca | 3 | $49 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 2 | $46 |
| Acadia Pharmaceuticals Inc | 1 | $43 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$264
- AJOVY$238
- Fycompa$226
- Epidiolex$220
- Briviact$125
- AFINITOR$115
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$109
How this compares
$4,436 in reported general payments places this provider in the 65th percentile of 1,996 neurology providers in California.
Other neurology in Fresno
- Eric FarbmanFresno$866K
- Perminder BhatiaFresno$279K
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
- Regina BerkovichWest Hollywood$3M
- Daniel BandariNewport Beach$2.6M
- Perry ShiehLos Angeles$2.4M
- Sandeep ThakkarIrvine$2M
- David LiebeskindLos Angeles$1.9M
- Jack SchimCarlsbad$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.